Screening for viral markers in volunteer and replacement blood donors in West Africa.
Identifieur interne : 000725 ( PubMed/Checkpoint ); précédent : 000724; suivant : 000726Screening for viral markers in volunteer and replacement blood donors in West Africa.
Auteurs : F. Sarkodie [Ghana] ; M. Adarkwa ; Y. Adu-Sarkodie ; D. Candotti ; J W Acheampong ; J P AllainSource :
- Vox sanguinis [ 0042-9007 ] ; 2001.
Descripteurs français
- KwdFr :
- ARN viral (sang), Adolescent, Adulte, Adulte d'âge moyen, Anticorps anti-HTLVI (sang), Anticorps anti-HTLVII (sang), Anticorps anti-VIH (sang), Anticorps antiviraux (sang), Anticorps de l'hépatite C (sang), Antigènes de surface du virus de l'hépatite B (sang), Antigènes viraux (sang), Bénévoles, Donneurs de sang, Dépistage systématique, Famille, Femelle, Ghana (épidémiologie), Humains, Mâle, Protéine de capside p24 du VIH (sang), Séroprévalence du VIH, Test ELISA, Transfusion sanguine (effets indésirables), Virémie (), Virémie (diagnostic), Virémie (sang), Virémie (transmission), Virémie (épidémiologie), Études séroépidémiologiques.
- MESH :
- diagnostic : Virémie.
- effets indésirables : Transfusion sanguine.
- sang : ARN viral, Anticorps anti-HTLVI, Anticorps anti-HTLVII, Anticorps anti-VIH, Anticorps antiviraux, Anticorps de l'hépatite C, Antigènes de surface du virus de l'hépatite B, Antigènes viraux, Protéine de capside p24 du VIH, Virémie.
- épidémiologie : Ghana, Virémie.
- Adolescent, Adulte, Adulte d'âge moyen, Bénévoles, Donneurs de sang, Dépistage systématique, Famille, Femelle, Humains, Mâle, Séroprévalence du VIH, Test ELISA, Virémie, Études séroépidémiologiques.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- Adolescent, Adult, Antibodies, Viral (blood), Antigens, Viral (blood), Blood Donors, Blood Transfusion (adverse effects), Enzyme-Linked Immunosorbent Assay, Family, Female, Ghana (epidemiology), HIV Antibodies (blood), HIV Core Protein p24 (blood), HIV Seroprevalence, HTLV-I Antibodies (blood), HTLV-II Antibodies (blood), Hepatitis B Surface Antigens (blood), Hepatitis C Antibodies (blood), Humans, Male, Mass Screening, Middle Aged, RNA, Viral (blood), Seroepidemiologic Studies, Viremia (blood), Viremia (diagnosis), Viremia (epidemiology), Viremia (prevention & control), Viremia (transmission), Volunteers.
- MESH :
- chemical , blood : Antibodies, Viral, Antigens, Viral, HIV Antibodies, HIV Core Protein p24, HTLV-I Antibodies, HTLV-II Antibodies, Hepatitis B Surface Antigens, Hepatitis C Antibodies, RNA, Viral.
- geographic , epidemiology : Ghana.
- adverse effects : Blood Transfusion.
- blood : Viremia.
- diagnosis : Viremia.
- epidemiology : Viremia.
- prevention & control : Viremia.
- transmission : Viremia.
- Adolescent, Adult, Blood Donors, Enzyme-Linked Immunosorbent Assay, Family, Female, HIV Seroprevalence, Humans, Male, Mass Screening, Middle Aged, Seroepidemiologic Studies, Volunteers.
Abstract
West Africa is a highly endemic area for viral infections. The prevalence of five viral markers was determined in Ghanaian blood donors.
PubMed: 11840974
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:11840974Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Screening for viral markers in volunteer and replacement blood donors in West Africa.</title><author><name sortKey="Sarkodie, F" sort="Sarkodie, F" uniqKey="Sarkodie F" first="F" last="Sarkodie">F. Sarkodie</name><affiliation wicri:level="1"><nlm:affiliation>Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Adarkwa, M" sort="Adarkwa, M" uniqKey="Adarkwa M" first="M" last="Adarkwa">M. Adarkwa</name></author><author><name sortKey="Adu Sarkodie, Y" sort="Adu Sarkodie, Y" uniqKey="Adu Sarkodie Y" first="Y" last="Adu-Sarkodie">Y. Adu-Sarkodie</name></author><author><name sortKey="Candotti, D" sort="Candotti, D" uniqKey="Candotti D" first="D" last="Candotti">D. Candotti</name></author><author><name sortKey="Acheampong, J W" sort="Acheampong, J W" uniqKey="Acheampong J" first="J W" last="Acheampong">J W Acheampong</name></author><author><name sortKey="Allain, J P" sort="Allain, J P" uniqKey="Allain J" first="J P" last="Allain">J P Allain</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11840974</idno><idno type="pmid">11840974</idno><idno type="wicri:Area/PubMed/Corpus">000718</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000718</idno><idno type="wicri:Area/PubMed/Curation">000718</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000718</idno><idno type="wicri:Area/PubMed/Checkpoint">000718</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000718</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Screening for viral markers in volunteer and replacement blood donors in West Africa.</title><author><name sortKey="Sarkodie, F" sort="Sarkodie, F" uniqKey="Sarkodie F" first="F" last="Sarkodie">F. Sarkodie</name><affiliation wicri:level="1"><nlm:affiliation>Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Adarkwa, M" sort="Adarkwa, M" uniqKey="Adarkwa M" first="M" last="Adarkwa">M. Adarkwa</name></author><author><name sortKey="Adu Sarkodie, Y" sort="Adu Sarkodie, Y" uniqKey="Adu Sarkodie Y" first="Y" last="Adu-Sarkodie">Y. Adu-Sarkodie</name></author><author><name sortKey="Candotti, D" sort="Candotti, D" uniqKey="Candotti D" first="D" last="Candotti">D. Candotti</name></author><author><name sortKey="Acheampong, J W" sort="Acheampong, J W" uniqKey="Acheampong J" first="J W" last="Acheampong">J W Acheampong</name></author><author><name sortKey="Allain, J P" sort="Allain, J P" uniqKey="Allain J" first="J P" last="Allain">J P Allain</name></author></analytic><series><title level="j">Vox sanguinis</title><idno type="ISSN">0042-9007</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Antibodies, Viral (blood)</term><term>Antigens, Viral (blood)</term><term>Blood Donors</term><term>Blood Transfusion (adverse effects)</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Family</term><term>Female</term><term>Ghana (epidemiology)</term><term>HIV Antibodies (blood)</term><term>HIV Core Protein p24 (blood)</term><term>HIV Seroprevalence</term><term>HTLV-I Antibodies (blood)</term><term>HTLV-II Antibodies (blood)</term><term>Hepatitis B Surface Antigens (blood)</term><term>Hepatitis C Antibodies (blood)</term><term>Humans</term><term>Male</term><term>Mass Screening</term><term>Middle Aged</term><term>RNA, Viral (blood)</term><term>Seroepidemiologic Studies</term><term>Viremia (blood)</term><term>Viremia (diagnosis)</term><term>Viremia (epidemiology)</term><term>Viremia (prevention & control)</term><term>Viremia (transmission)</term><term>Volunteers</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (sang)</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps anti-HTLVI (sang)</term><term>Anticorps anti-HTLVII (sang)</term><term>Anticorps anti-VIH (sang)</term><term>Anticorps antiviraux (sang)</term><term>Anticorps de l'hépatite C (sang)</term><term>Antigènes de surface du virus de l'hépatite B (sang)</term><term>Antigènes viraux (sang)</term><term>Bénévoles</term><term>Donneurs de sang</term><term>Dépistage systématique</term><term>Famille</term><term>Femelle</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Mâle</term><term>Protéine de capside p24 du VIH (sang)</term><term>Séroprévalence du VIH</term><term>Test ELISA</term><term>Transfusion sanguine (effets indésirables)</term><term>Virémie ()</term><term>Virémie (diagnostic)</term><term>Virémie (sang)</term><term>Virémie (transmission)</term><term>Virémie (épidémiologie)</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term><term>Antigens, Viral</term><term>HIV Antibodies</term><term>HIV Core Protein p24</term><term>HTLV-I Antibodies</term><term>HTLV-II Antibodies</term><term>Hepatitis B Surface Antigens</term><term>Hepatitis C Antibodies</term><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Blood Transfusion</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Virémie</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Transfusion sanguine</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>ARN viral</term><term>Anticorps anti-HTLVI</term><term>Anticorps anti-HTLVII</term><term>Anticorps anti-VIH</term><term>Anticorps antiviraux</term><term>Anticorps de l'hépatite C</term><term>Antigènes de surface du virus de l'hépatite B</term><term>Antigènes viraux</term><term>Protéine de capside p24 du VIH</term><term>Virémie</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Viremia</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Virémie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Blood Donors</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Family</term><term>Female</term><term>HIV Seroprevalence</term><term>Humans</term><term>Male</term><term>Mass Screening</term><term>Middle Aged</term><term>Seroepidemiologic Studies</term><term>Volunteers</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Bénévoles</term><term>Donneurs de sang</term><term>Dépistage systématique</term><term>Famille</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Séroprévalence du VIH</term><term>Test ELISA</term><term>Virémie</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">West Africa is a highly endemic area for viral infections. The prevalence of five viral markers was determined in Ghanaian blood donors.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11840974</PMID><DateCreated><Year>2001</Year><Month>07</Month><Day>13</Day></DateCreated><DateCompleted><Year>2002</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0042-9007</ISSN><JournalIssue CitedMedium="Print"><Volume>80</Volume><Issue>3</Issue><PubDate><Year>2001</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Vox sanguinis</Title><ISOAbbreviation>Vox Sang.</ISOAbbreviation></Journal><ArticleTitle>Screening for viral markers in volunteer and replacement blood donors in West Africa.</ArticleTitle><Pagination><MedlinePgn>142-7</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">West Africa is a highly endemic area for viral infections. The prevalence of five viral markers was determined in Ghanaian blood donors.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Replacement and volunteer blood donors were screened using enzyme immunoassays (EIAs) for hepatitis B surface antigen (HBsAg), human immunodeficiency virus antibodies (anti-HIV), HIV p24 antigen, human T-cell lymphocytotrophic virus-I and -II antibodies (anti-HTLV-I/II) and hepatitis C virus antibodies (anti-HCV).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">HBsAg was present at an equally high frequency (15%) in young volunteer (median age 18 years) and older replacement (median age 33 years) blood donors. In contrast, the prevalence of anti-HIV and anti-HCV was significantly higher in replacement blood donors (2.4 and 0.3%, respectively, P < 0.001). HCV RNA was detected in 74 or 55% of seropositive donors, depending on the confirmatory criteria used. No p24 antigen-positive/anti-HIV-negative donations were found. The prevalence of HTLV-I/II was generally low (0.5%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">All blood donations should be screened for hepatitis B virus (HBV), HIV and HCV markers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sarkodie</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Blood Service, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adarkwa</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Adu-Sarkodie</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Candotti</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Acheampong</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Allain</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vox Sang</MedlineTA><NlmUniqueID>0413606</NlmUniqueID><ISSNLinking>0042-9007</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016655">HIV Core Protein p24</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015481">HTLV-I Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015482">HTLV-II Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018937">Hepatitis C Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="Y">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016655" MajorTopicYN="N">HIV Core Protein p24</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015528" MajorTopicYN="N">HIV Seroprevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015481" MajorTopicYN="N">HTLV-I Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015482" MajorTopicYN="N">HTLV-II Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018937" MajorTopicYN="N">Hepatitis C Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="Y">Mass Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014838" MajorTopicYN="N">Volunteers</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>2</Month><Day>14</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>2</Month><Day>14</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>2</Month><Day>14</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11840974</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Ghana</li></country></list><tree><noCountry><name sortKey="Acheampong, J W" sort="Acheampong, J W" uniqKey="Acheampong J" first="J W" last="Acheampong">J W Acheampong</name><name sortKey="Adarkwa, M" sort="Adarkwa, M" uniqKey="Adarkwa M" first="M" last="Adarkwa">M. Adarkwa</name><name sortKey="Adu Sarkodie, Y" sort="Adu Sarkodie, Y" uniqKey="Adu Sarkodie Y" first="Y" last="Adu-Sarkodie">Y. Adu-Sarkodie</name><name sortKey="Allain, J P" sort="Allain, J P" uniqKey="Allain J" first="J P" last="Allain">J P Allain</name><name sortKey="Candotti, D" sort="Candotti, D" uniqKey="Candotti D" first="D" last="Candotti">D. Candotti</name></noCountry><country name="Ghana"><noRegion><name sortKey="Sarkodie, F" sort="Sarkodie, F" uniqKey="Sarkodie F" first="F" last="Sarkodie">F. Sarkodie</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000725 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000725 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:11840974
|texte= Screening for viral markers in volunteer and replacement blood donors in West Africa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:11840974" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |